As of 2025-07-12, the Relative Valuation of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd (600613.SS) is 3.82 CNY. This relative valuation is based on P/E multiples. With the latest stock price at 6.77 CNY, the upside of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd based on Relative Valuation is -43.5%.
The range of the Relative Valuation is 2.78 - 4.54 CNY.
| Range | Selected | |
| Trailing P/E multiples | 23.7x - 37.2x | 32.0x |
| Forward P/E multiples | 21.1x - 27.9x | 24.0x |
| Fair Price | 2.78 - 4.54 | 3.82 |
| Upside | -59.0% - -33.0% | -43.5% |
| Date | P/E |
| 2025-05-30 | 55.43 |
| 2025-05-29 | 55.43 |
| 2025-05-28 | 54.23 |
| 2025-05-27 | 54.66 |
| 2025-05-26 | 53.80 |
| 2025-05-23 | 54.40 |
| 2025-05-22 | 54.32 |
| 2025-05-21 | 54.91 |
| 2025-05-20 | 55.00 |
| 2025-05-19 | 54.57 |
| 2025-05-16 | 54.40 |
| 2025-05-15 | 53.03 |
| 2025-05-14 | 53.03 |
| 2025-05-13 | 53.37 |
| 2025-05-12 | 53.20 |
| 2025-05-09 | 53.46 |
| 2025-05-08 | 53.55 |
| 2025-05-07 | 53.46 |
| 2025-05-06 | 53.12 |
| 2025-04-30 | 51.92 |
| 2025-04-29 | 52.52 |
| 2025-04-28 | 51.75 |
| 2025-04-25 | 52.78 |
| 2025-04-24 | 53.03 |
| 2025-04-23 | 52.78 |
| 2025-04-22 | 53.20 |
| 2025-04-21 | 52.35 |
| 2025-04-18 | 51.49 |
| 2025-04-17 | 51.41 |
| 2025-04-16 | 50.55 |
| 2025-04-15 | 51.58 |
| 2025-04-14 | 51.32 |
| 2025-04-11 | 50.38 |
| 2025-04-10 | 50.64 |
| 2025-04-09 | 49.01 |
| 2025-04-08 | 48.41 |
| 2025-04-07 | 50.21 |
| 2025-04-03 | 55.77 |
| 2025-04-02 | 55.17 |
| 2025-04-01 | 55.68 |
| 2025-03-31 | 53.37 |
| 2025-03-28 | 54.91 |
| 2025-03-27 | 55.68 |
| 2025-03-26 | 55.34 |
| 2025-03-25 | 54.32 |
| 2025-03-24 | 54.49 |
| 2025-03-21 | 55.00 |
| 2025-03-20 | 56.03 |
| 2025-03-19 | 55.77 |
| 2025-03-18 | 55.51 |